We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 10,000 results
  1. Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review

    Purpose

    We undertook a scoping review of the literature to synthesize what is known about lymphoma survivorship and develop a comprehensive set of...

    Melanie Powis, Saidah Hack, ... Vishal Kukreti in Journal of Cancer Survivorship
    Article 04 December 2023
  2. Renomegaly and acute kidney injury as primary manifestations of non-Hodgkin’s lymphoma: a report of three cases

    Background

    In adults with non-Hodgkin's lymphoma, renal enlargement and acute kidney injury occur infrequently at first presentation, especially in T...

    Yu Bai, Yuanyuan Zheng, ... Wenhu Liu in Diagnostic Pathology
    Article Open access 08 December 2023
  3. Risk factors for Non-Hodgkin’s lymphoma in autoimmune disease: a large database analysis

    Immune dysregulation in autoimmune diseases (ADs) is a risk factor for the development of Non-Hodgkin’s lymphoma (NHL). However, the underlying...

    Suma Sri Chennapragada, Shriya Goyal, ... Poornima Ramadas in Annals of Hematology
    Article 05 July 2024
  4. An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma

    Anti-PD-1 immunotherapy has been widely applied in patients with some types of lymphoma. Classical Hodgkin’s lymphoma (cHL) is highly sensitive to...

    Lin Yang, Qiuling Zhao, ... Liangliang Dong in Clinical and Experimental Medicine
    Article 27 April 2023
  5. Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin’s lymphoma

    Background

    The NFLymSI-18 is a patient-reported outcome measure comprised of the highest priority symptoms, emotional concerns, treatment side...

    Courtney N. Hurt, Karen Kaiser, ... David Cella in Journal of Patient-Reported Outcomes
    Article Open access 09 July 2024
  6. The association between primary Sjogren’s syndrome and non-Hodgkin’s lymphoma: a systematic review and meta-analysis of cohort studies

    Primary Sjögren’s syndrome (pSS), a chronic autoimmune condition, has been associated with an increased risk of several cancers. This study aims to...

    Narges Ansari, Mansour Salesi in Clinical Rheumatology
    Article 09 May 2024
  7. A Case of Medullary Carcinoma of Colon Morphologically Resembling Non-Hodgkin’s Lymphoma

    Medullary carcinoma of the colon is an unusual and unique histologic subtype of colorectal cancer. It is strongly associated with microsatellite...

    Md Ali Osama, Shashi Dhawan, Arvind Kumar in Indian Journal of Surgical Oncology
    Article 05 January 2024
  8. Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study

    Cancer cachexia is a disorder that affects patient outcomes. The present study prospectively evaluated the prognostic value of the cachexia index...

    So Okubo, Kohei Shinmura, ... Tomonori Nakazato in Annals of Hematology
    Article 27 November 2023
  9. Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma

    Objectives

    The randomized controlled trial Inter-B-NHL ritux 2010 showed overall survival (OS) benefit and event-free survival (EFS) benefit with the...

    Béranger Lueza, Anne Aupérin, ... Julia Bonastre in The European Journal of Health Economics
    Article Open access 14 April 2023
  10. Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study

    Introduction

    Despite rasburicase's proven efficiency in Caucasians, Japanese, and Koreans, studies evaluating the safety and effectiveness of...

    Tianyou Wang, Xiaofan Zhu, ... Minlu Zhang in Drugs in R&D
    Article Open access 10 May 2023
  11. Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin’s lymphoma: 2-year results of a phase 1 trial

    This study reported 2-year efficacy and safety of relma-cel in Chinese patients with relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (B-NHL)....

    Zhitao Ying, Yan Xie, ... Jun Zhu in Bone Marrow Transplantation
    Article 07 December 2022
  12. Texture analysis of conventional magnetic resonance imaging and diffusion-weighted imaging for distinguishing sinonasal non-Hodgkin’s lymphoma from squamous cell carcinoma

    Purpose

    To evaluate the value of texture analysis (TA) of conventional magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) in the...

    Guo-Yi Su, Jun Liu, ... Fei-Yun Wu in European Archives of Oto-Rhino-Laryngology
    Article 22 June 2022
  13. Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study

    The selective phosphatidylinositol 3-kinase δ inhibitor zandelisib demonstrated favorable safety and efficacy [objective response rate (ORR) 79%] in...

    Hideki Goto, Koji Izutsu, ... Kenichi Ishizawa in International Journal of Hematology
    Article Open access 15 September 2022
  14. Hypercalcemia in non-Hodgkin’s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D

    Abstract

    Hypercalcemia occurs in up to 30% of patients with malignancies and can be due to osteolysis by metastases, parathyroid hormone-related...

    A.R. Gonciulea, Y. Wang, ... D.E. Sellmeyer in Osteoporosis International
    Article 06 July 2021
  15. The role of interleukins and the widely studied TNF-α in non-Hodgkin’s lymphoma

    Non-Hodgkin’s lymphoma is a relatively common cancer with malignant tendencies. Although there is no current cure for the disease, research has been...

    Kyle P. D’mello, Lei Zhao, ... Yujiang Fang in Medical Oncology
    Article 09 April 2021
  16. Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin’s lymphoma

    Background

    Paraneoplastic Cerebellar degeneration (PCD) is one of the classical paraneoplastic syndromes (PNS) which is characterised by subacute...

    Satyan Nanda, Rahul Handa, ... Nalin Malhotra in Neurological Sciences
    Article 08 February 2021
  17. Multiple thrombi mimicking metastases in the right atrium of patients with non-Hodgkin’s lymphoma diagnosed by multimodal cardiac imaging: one case report

    Background

    Right-side heart mass can be found incidentally on routine transthoracic echocardiography (TTE). Accurate diagnosis of cardiac mass often...

    Zhiqiang Hu, Shuai Yuan, Yun Mou in Journal of Cardiothoracic Surgery
    Article Open access 01 April 2024
  18. Cytomegalovirus retinitis in patients of non-Hodgkin’s lymphoma: clinical presentations and outcomes

    Background

    Cytomegalovirus (CMV) retinitis in patients with Non-Hodgkin’s Lymphoma (NHL) can occur even in the presence of high CD 4 counts and can...

    Subhakar Reddy, Mudit Tyagi, ... Hitesh Agrawal in Journal of Ophthalmic Inflammation and Infection
    Article Open access 06 October 2021
  19. Unmasking an unusual presentation of Hodgkin’s lymphoma masquerading as ocular inflammation: a case report

    Background

    Hodgkin’s lymphoma (HL) is an extremely rare cause of ocular inflammation that is usually not considered in the typical workup of uveitis...

    Anna Zein-El-Din, Rami Abdo, ... Sayeh Pourjavan in Journal of Medical Case Reports
    Article Open access 04 July 2024
  20. Maxillary Diffuse Large B-Cell Lymphoma Enshrouded as Osteomyelitis: A Case Report

    Extranodal non-Hodgkin’s lymphoma (NHL) afflicting the head and neck region is rare, accounting for only about 5%. Diffuse large B-cell lymphoma...

    Akansha Vyas, Ashi Chug, ... Preeti Kolse in Journal of Maxillofacial and Oral Surgery
    Article 08 April 2024
Did you find what you were looking for? Share feedback.